Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?

British Journal of Cancer

Volumn 77, Issue 11, 1998, Pages 1900-1906

  Ribatti, D ^a,b   Nico, B ^a   Vacca, A ^a   Marzullo, A ^a   Calvi, N ^a   Roncali, L ^a   Dammacco, F ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Angiogenesis; B cell non Hodgkin's lymphoma; Mast cell; Tumour progression

Indexed keywords

ANGIOGENESIS; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MAST CELL; MICROVASCULATURE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STROMA; TUMOR GROWTH;

EID: 0031748831     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.316     Document Type: Article

References (45)

1. Alessandri G, Raju KS and Gullino PM (1984) Characterization of a chemoattractant for endothelium induced by angiogenic effectors. Cancer Res 44: 1579-1584
2. Aznavoorian S, Murphy AN, Stetler-Stevenson WG and Liotta LA (1993) Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368-1383
3. Beil WJ, Login GR, Galli SJ and Dvorak AM (1994) Ultrastructural immunogold localization of tumor necrosis factor-α on the cytoplasmic granules of rat peritoneal mast cells with rapid microwave fixation. J Allergy Clin Immunol 94: 531-536
4. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG and Gruber BL (1997) Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 99: 2691-2700
5. Bussolino F, Ziche M, Wang JM, Alessi D, Morbidelli L, Cremona O, Bosia A, Marchisio PC and Mantovani A (1991) In vitro and in vivo activation of endothelial cells by colony stimulating factors. J Clin Invest 87: 986-995
6. Carbone PP, Kaplan HS, Musshof K, Smithers DW and Tubiana M (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res 31: 1860-1861
7. Castellot JJ, Karnovsky MJ and Spiegelman BM (1982) Differentiation-dependent stimulation of neovascularization and endothelial cell chemotaxis by 3T3 adipocytes. Proc Natl Acad Sci USA 79: 5597-5601
8. Dethlefsen SM, Matsuura N and Zetter BR (1994) Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Mestastasis 14: 395-408
9. Elias H and Hyde DM (1983) Stereological measurements of isotropic structures. In A Guide to Practical Stereology, Elias H and Hyde DM (eds), pp 25-44. Karger: Basle.
10. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31
11. Folkman J and Brem H (1992) Angiogenesis and inflammation. In Inflammation: Basic Principles and Clinical Applications, Gallin JI, Goldstein M and Snyderman R (eds), pp 821-839. Raven Press: New York
12. Folkman J and Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934.
13. Folkman J, Watson K, Ingber D and Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61
14. Gruber BL, Marchese MJ and Kew R (1995) Angiogenic factors stimulate mast cell migration. Blood 86: 2488-2493
15. Grutzkan A, Kruger-Krasagakes S, Kogel H, Schwarz C, Henz BM and Moller A (1996) Synthesis, storage and release of the vascular endothelial growth factor by human mast cells. Mol Biol Cell 7: 352A
16. Hamada J, Cavanaugh PG and Lotan O (1992) Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br J Cancer 66: 349-354
17. Ishai-Michaeli R, Svahn CM, Chajek-Shaul T, Korner G, Ekre HP and Vlodavsky I (1992) Importance of size and sulphation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix. Biochemistry 31: 2080-2088
18. Jakobson AM and Hahnenberger R (1991) Antiangiogenic effect of heparin and other sulphated glycosaminoglycans in the chick embryo chorioallantoic membrane. Pharmacol Toxicol 69: 122-126
19. Joensuu H, Klemi PJ and Jalkanen S (1990) Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study. Cancer 65: 2564-2571
20. Kessler DA, Langer RS, Pless NA and Folkman J (1976) Mast cells and tumor angiogenesis. Int J Cancer 18: 703-709
21. Kittas C, Hansmann M-L, Borisch B, Feller AC and Lennert K (1985) The blood microvasculture in T-cell lymphomas. A morphological, ultrastructural and immunohistochemical study. Virchows Arch (Pathol Anat) 405: 439-452
22. Meininger CJ and Zetter BR (1992) Mast cells and angiogenesis. Semin Cancer Biol 3: 73-79
23. Mignatti P and Rifkin DB (1993) Biology and biochemistry of proteinases in tumor invasion. Physiological Rev 73: 161-195
24. Motro B, Itin A, Sachs L and Keshet E (1990) Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 87: 4068-4072
25. Norrby K (1993) Heparin and angiogenesis: a low molecular weight fraction inhibits and a high-molecular weight fraction stimulates angiogenesis systematically. Haemostasis 23 (suppl. 1): 144-149
26. Norrby K (1996) Interleukin-8 and de novo mammalian angiogenesis. Cell Prolif 29: 315-323
27. Norrby K and Sorbo J (1992) Heparin enchances angiogenesis by a systemic mode of action. Int J Exp Pathol 73: 1471-55
28. Norrby K and Woolley D (1993) Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumour tissue. Adv Biosci 89: 71-115
29. Pepper MS, Wasi S, Ferrara N, Orci L and Montesano R (1994) In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res 210: 298-305
30. Poole TJ and Zetter BR (1983) Mast cell chemotaxis to tumor derived factors. Cancer Res 43: 5857-5862
31. Qu Z, Leibler JM, Powers MR, Galey T, Ahmadi P, Huang XN, Ansel JC, Butterfield JH, Planck SR and Rosenbaum JT (1995) Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 147: 564-573
32. Ribatti D, Roncali L, Nico B and Bertossi M (1987) Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anat 130: 257-263
33. Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L and Dammacco F (1996) Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol 56: 54-63
34. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehr JH and Fauci AS (1986) Transforming growth factor type-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167-4171
35. Sorbo J, Jakobsson A and Norrby K (1994) Mast cell histamine is angiogenic through receptors for histamine 1 and histamine 2. Int J Exp Pathol 75: 43-50
36. Starkey JR, Crowle PK and Taubenberger S (1988) Mast cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 42: 48-52
37. Taylor S and Folkman J (1982) Protamine is an inhibitor of angiogenesis. Nature 297: 307-312
38. The non-Hodgkin's lymphoma pathologic classification project (1989) National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 60: 2403-2411
39. Thorton SC, Mueller SM and Levine EM (1983) Human endothelial cells: use of heparin in cloning and long term cultivation. Science 222: 623-625
40. Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S and Dammacco F (1993) Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 72: 455-161
41. Vacca A, Ranieri G, Ribatti D, Di Stefano R, Caloro D, Serio G, Di Loreto M, Silvestris F and Dammacco F (1994) Differential expression of two ICAM-1 epitopes and LFA-1 chains in B-cell non-Hodgkin's lymphomas. Eur J Haematol 53: 85-92
42. Vacca A, Ribatti D, Fanelli M, Costantino F, Nico B, Di Stefano R, Serio D and Dammacco F (1996) Expression of tenascin is related to histologic malignancy and angiogenesis in B-cell non-Hodgkin's lymphomas. Leuk Lymphoma 22: 473-481
43. Wain SL, Braylan RC and Borowitz MJ (1987) Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The South-Eastern Cancer Study Group experience. Cancer 60: 2403-2411
44. Wilks JW, Scott PS, Urla LK and Cocuzza JM (1991) Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin. Int J Radiat Biol 60: 73-77
45. Yayou A, Kalgsbrun M, Esko JD, Leder P and Ornitz DM (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848